Skip to records

Therapeutics

229Aging Biotech
100 of 229 records

MTRX31

Source date not recordedAnalyse record ↗

Preclinical mitochondrial-targeted small molecule intended to rebalance fat and carbohydrate oxidation in metabolically unhealthy obesity.

Modality
mitochondrial-targeted small molecule
Availability (US)
Preclinical development
Biomarkers
fat mass; lean mass; insulin sensitivity; glucose tolerance; mitochondrial substrate oxidation
Hallmark targeted
mitochondrial dysfunction, deregulated nutrient sensing
Kind
investigational drug